Childhood, Adolescent and Young Adulthood Cancer Risk in BRCA1 or BRCA2 Pathogenic Variant Carriers

Investigators evaluated this risk and to inform clinical care of young BRCA1/2 PV carriers and genetic testing for CAYA cancer patients.